Mondaq USA: Food, Drugs, Healthcare, Life Sciences
Gibson, Dunn & Crutcher
Halfway through 2019 and the third year of the Trump Administration, we continue to observe complex trends in the health care regulatory and enforcement environment impacting providers.
Dentons
The TGA has successfully brought a claim against Peptide Clinics Australia Pty Ltd for non-compliance with the new advertising regime which includes higher penalties for therapeutic goods advertising offences.
Foley Hoag LLP
We do expect there to be further revisions and amendments before PDPRA makes is to the Floor for a vote.
Reed Smith
The Centers for Medicare & Medicaid Services (CMS) has published its proposed Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC)
Cowan Liebowitz & Latman PC
A battle between two dietary supplement manufacturers has revived interested in the intersection between the Lanham Act and federal labeling regulations.
Mintz
We've previously blogged about the regulation of CBD by the Food and Drug Administration (FDA), and it appears that the dialogue around CBD
Holland & Knight
On the FDA rulemaking front, there is not much new to report since last month.
Holland & Knight
Among the notable changes, CMS is updating several provisions
Dentons
On July 23, 2019, the United States Senate Committee on Banking, Housing, and Urban Affairs held a public hearing on the cannabis industry titled "Challenges for Cannabis
Dentons
During the 115th United States Congress, several Bills were introduced to legalize marijuana at the federal level. The Bills that received the most attention were: (
BakerHostetler
The 21st Century Cures Act (Cures Act), signed into law on Dec. 13, 2016, was designed to accelerate medical product development and bring new innovations
BakerHostetler
According to Wikipedia, digital therapeutics can be defined as a treatment or therapy that utilizes digital health technologies to spur changes in patient behavior.
BakerHostetler
The FDA published a new guidance for labeling of added sugars.
Buchanan Ingersoll & Rooney PC
The popularity of products containing cannabidiol, more widely known as CBD, has exploded.
Proskauer Rose LLP
In the latest volley between participants and group health plans over mental health services coverage, a federal district court in California denied United Healthcare's motion to dismiss a putative class action ...
Mintz
The proposed 2020 Outpatient Prospective Payment (OPPS) rule was published on August 9, 2019. Buried in the 819 pages of proposed changes and justifications
Ford & Harrison LLP
In the last year, a record number of states have amended or enacted laws which regulate marijuana testing, accommodations, and use.
Hogan Lovells
The U.S. Food and Drug Administration (FDA) has published a new draft guidance titled "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment."
Ropes & Gray LLP
The fourth installment of Ropes & Gray's podcast series, Non-binding Guidance, dives into the use of real-world evidence in drug development
Ropes & Gray LLP
This article by counsel Valerie Bonham and partners Kirsten Mayer and Mark Barnes was published by Law360 on August 8, 2019.
Latest Video
Most Popular Recent Articles
Jones Day
Data privacy- and security-related class actions appear to be on the rise, and effectively defending them requires the right mix of substantive and procedural knowledge.
Jones Day
On the heels of the European Union's General Data Protection law, which went into effect in May 2018
Butler Snow LLP
Many state legislatures across the country have enacted statutory measures to limit the amount of compensatory and/or punitive damages recoverable ...
BakerHostetler
Partners Carl Hittinger and Jeffry Duffy authored an article published by The Legal Intelligencer on July 27, 2018.
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2018, published the Calendar Year (CY) 2019 Final Rule for the Medicare Physician Fee Schedule (PFS).
Dentons
FDA expedites its efforts to develop rules for CBD and plans to report on its progress by late summer/early fall.
Davis & Gilbert
The U.S. Patent and Trademark Office (USPTO) has traditionally refused registration of cannabis and cannabis-related offerings because "use in commerce" under the Trademark Act means "use in lawful commerce" and such offerings were prohibited under federal law.
Squire Patton Boggs LLP
On June 25, 2019, Illinois governor J.B. Pritzker signed HB 1438, the Illinois Cannabis Regulation and Taxation Act ("CRTA"), which, as of January 1, 2020, legalizes recreational use and possession of marijuana by adults...
Cozen O'Connor
Iowa AG Tom Miller issued a statement regarding the legality of hemp and cannabidiol products under state law after Congress passed the Agriculture Improvement Act of 2018 legalizing CBD derived from industrial hemp ...
Arnold & Porter
On May 26, 2017, the new European Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) entered into force.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with